Skip to content
Clinical Trials – home

Gemeinschaftspraxis Drs. Grosskopf

Verified siteinfo

Germany Ahornstrasse 2a, 94574 Wallerfing, Germany

  • 9 trials recruiting
  • Arteriosclerosis · Cardiac failure · Hypertriglyceridaemia
  • Adults and children

About Specializations

Gemeinschaftspraxis Drs. Grosskopf in Wallerfing, Germany specialises in clinical trials of conditions such as Arteriosclerosis, Cardiac failure, Hypertriglyceridaemia, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The site is conducting research on the immune response to a novel respiratory syncytial virus vaccine in adults aged 60 and older, aiming to improve protection against seasonal infections.

  • Evaluation of humoral immunity after revaccination
  • Assessment of vaccine safety in elderly participants
  • Timing of booster doses across different RSV seasons

Gemeinschaftspraxis Drs. Grosskopf contributes valuable data to the field of respiratory viral prevention.

Skin and Connective Tissue Diseases

A comparative study is testing a new topical formulation containing clotrimazole and betamethasone dipropionate for the treatment of moderately to severely inflamed candidiasis of the skin, with the goal of enhancing therapeutic outcomes.

  • Comparison of combination ointment versus standard therapy
  • Safety profile of anti‑fungal and anti‑inflammatory agents together
  • Patient‑reported symptom relief and healing rates

The practice’s dermatology focus supports advances in managing fungal skin infections.

Virus Diseases

Research at the center also explores broader viral health by monitoring immune responses to revaccination with an RSVPreF3 OA vaccine, seeking to strengthen defenses against common respiratory viruses in older adults.

  • Immunogenicity across multiple vaccination seasons
  • Cross‑reactivity with other respiratory pathogens
  • Long‑term safety monitoring post‑vaccination

These efforts align with the site’s commitment to combating viral diseases within the community.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Site location
Ahornstrasse 2a94574 WallerfingGermany
Recruiting now
9 trials
Conditions studied
24
Partner status
Verified site

More sites in WallerfingGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

25 clinical trials

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Dyslipidaemia

Recruiting

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:A. Menarini International Licensing S.A.

Pharyngitis

Recruiting

Testing benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Study on the Effectiveness and Safety of Ivermectin Cream Compared to a Drug Combination for Patients with Papulopustular Rosacea

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Dermapharm AG

Skin candida

Recruiting

Study Comparing Effects of Ointments with Clotrimazole and Betamethasone Dipropionate for Patients with Moderate to Severe Skin Yeast Infections

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clotrimazole
  • Sponsor:Dermapharm AG

Irritable bowel syndrome

Not yet recruiting

Efficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Artemisia absinthium, herba REC., ethanol. EXTR. 1:2,3
  • Sponsor:Weleda AG

Pharyngitis

Not yet recruiting

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Acne

Not yet recruiting

Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Clindamycin
  • Sponsor:Dermapharm AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.